NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$21.12
-0.14 (-0.66%)
▼
5d:
-0.61%
30d:
+2.47%
90d:
+12.4%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 26, 2026
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NRC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.10
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.52
17.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $21.12, which is considered fair relative to its 30-day fair value range of $20.37 to $21.96. The stock's valuation (Forward PE: 20.1) is in line with its historical norms (20.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.93, while resistance sits at $22.13.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+23.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.93, while resistance sits at $22.13.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+23.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$20.37 -
$21.96
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.1% below Wall St target ($26.00)
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$20.37 -
$21.96
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.93
Resistance Level
$22.13
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.11
Wall Street Target
$26.00
(+23.1%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-44.0%
Profit Margin
4.2%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
20.1 vs 20.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$21.10
(0%)
2-Year Target
$21.08
(0%)
3-Year Target
$21.06
(0%)
3-Yr Target (if PE normalizes)
(PE: 20→20)
PE COMPRESSION
$21.04
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 218.2%)
$71.48
(+238%)
Base:
(SPY PE: 20.1, Growth: 218.2%)
$71.28
(+238%)
Bear:
(PE: 17.1, Growth: 218.2%)
$60.59
(+187%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.23
Bull Case
$25.50
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$21.12
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$16.16
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 7:17 PM ET
Data refreshes hourly during market hours. Next update: 8:17 PM
Data refreshes hourly during market hours. Next update: 8:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$33 | 45 HOLD |
